Bright Minds Biosciences (DRUG) has had the highest return since August 13, 2024 by a small-cap US stock, returning 7,388%.
| ASSET | % RETURN |
|---|---|
Bright Minds Biosciences (DRUG) | 7,388% |
Monopar Therapeutics (MNPR) | 2,400.86% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 2,057.22% |
United States Antimony (UAMY) | 2,037.66% |
Almonty Industries Inc Common Shares (ALM) | 1,192.37% |
Avino Silver & Gold Mines (ASM) | 1,082.42% |
Amprius Technologies (AMPX) | 1,078.3% |
AXT (AXTI) | 1,042.8% |
SEALSQ (LAES) | 1,006.15% |
Kodiak Sciences (KOD) | 872% |
Zepp Health (ZEPP) | 804.44% |
Babcock & Wilcox Enterprises (BW) | 798.11% |
Trilogy Metals (TMQ) | 771.4% |
Nutex Health (NUTX) | 714.32% |
ThredUp (TDUP) | 704.37% |
LightPath Technologies (LPTH) | 670.75% |
Inhibrx Biosciences (INBX) | 669.48% |
Microvast (MVST) | 651.75% |
Nova Minerals (NVA) | 638.32% |
Amylyx Pharmaceuticals (AMLX) | 621.83% |
Ventyx Biosciences (VTYX) | 611.73% |
Richtech Robotics Inc Class B Common Stock (RR) | 603.74% |
Unusual Machines (UMAC) | 603.54% |
Sify Technologies (SIFY) | 601.43% |
Power Solutions International, Inc Common Stock (PSIX) | 597.02% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
